The Effect of Chitosan Supplementation on Liver Function, Hepatic Steatosis Predictors, and Metabolic Indicators in Adults with Non-Alcoholic Fatty Liver Disease: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial
Posted inClinical Updates Diabetes & Endocrinology Gastroenterology news Specialties

The Effect of Chitosan Supplementation on Liver Function, Hepatic Steatosis Predictors, and Metabolic Indicators in Adults with Non-Alcoholic Fatty Liver Disease: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial

This clinical trial evaluates chitosan supplementation's impact on liver health and metabolic markers in adults with NAFLD, showing potential benefits alongside a low-calorie diet.
Mediterranean Diet Combined with Early Time-Restricted Feeding: A Promising Strategy for MASLD – Insights from the CHRONO-NAFLD Trial
Posted inClinical Updates Diabetes & Endocrinology Gastroenterology news Specialties

Mediterranean Diet Combined with Early Time-Restricted Feeding: A Promising Strategy for MASLD – Insights from the CHRONO-NAFLD Trial

A 12-week hypocaloric Mediterranean diet with early time-restricted feeding improved glycaemic control and cardiometabolic risk in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) compared to unrestricted timing or late time-restricted feeding.
Culturally Adapted Dementia Caregiver Support in Vietnam: New Evidence from the REACH VN Clinical Trial
Posted inClinical Updates Neurology news Specialties

Culturally Adapted Dementia Caregiver Support in Vietnam: New Evidence from the REACH VN Clinical Trial

A culturally adapted, multicomponent caregiver intervention (REACH VN) reduced psychological distress and stress among Vietnamese dementia caregivers at 3 months, though most benefits were not sustained at 6 months, highlighting both promise and challenges for scalable dementia care support in low-resource settings.